Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-20T05:16:50.787Z Has data issue: false hasContentIssue false
  • English
  • Français

A Year's Experience of Intravenous Insulin in the Hypoglycaemic Shock Treatment of Schizophrenia

Published online by Cambridge University Press:  08 February 2018

R. A. Sandison  and
James S. McGregor
R. A. Sandison
Affiliation:
Warlingham Park Hospital
James S. McGregor
Affiliation:
Warlingham Park Hospital
Get access Rights & Permissions [Opens in a new window]

Extract

In a preliminary report (Brit. Med. Journ., 2, 310, 1940), two modifications were introduced in Sakel's technique for the insulin treatment of schizophrenia, with the primary object of continuing the treatment under wartime conditions. The first and most important of these was concerned with the saving of sugar. This simple method, by which glucose is given intravenously and is followed by a drink of potato soup as soon as the patient is awake, has already been fully described by us. We discovered incidentally that this method effected a saving of insulin amounting to 46.6 per cent. in seven patients. Various critics have asked why other workers have not effected a saving by using intravenous insulin. Further, we have been asked what advantages are to be gained by giving insulin intravenously apart from this saving of the drug; whether intravenous insulin adds any dangers to the treatment, and whether it brings about a remission in schizophrenia comparable with intramuscular insulin. We have had more than a year's experience with the use of intravenous insulin, and this paper aims at describing our first year of this experience and answering the questions set out above. We may mention that in 24 additional patients treated, an average saving of 28.3 per cent. of insulin has been effected.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 88 , Issue 372 , July 1942 , pp. 387 - 406
Copyright
Copyright © Royal College of Psychiatrists, 1942 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bailey, K. (1939), M.D. Thesis (Camb.).Google Scholar
Bardenat, and Leonardon, (1939), Ann. Méd.-psychol. (Pt. 1), 97, 220.Google Scholar
Braunmühl, A. von (1938), Die Insulinschockbehandlung der Schizophrenie. Google Scholar
Dameshek, W., and Myerson, (1935), Arch. Neur. and Psychiat., 33, 1.CrossRefGoogle Scholar
Day, G. W., Niver, E. O., and Greenberg, M. M. (1938), Am. Journ. Clin. Path., 8, 206.CrossRefGoogle Scholar
Day, G. W., and Niver, E. O. (1937), Texas State J. Med., 33, 263.Google Scholar
Dussik, K. J. (1938), Klin. Wochenschr., 17, 769.Google Scholar
Fischer, M. (1938), Ibid., 8, 206; ibid., 17, 886; Monats. f. Psychiat. u. Neurol., 100, 221.Google Scholar
Folin, O., and Wu, H. (1919), Journ. Biol. Chem., 38, 81.Google Scholar
Idem (1920), ibid., 41, 367.Google Scholar
Foerster, O., and Gagel, O. (1933), Z. Ges. Neurol. u. Psychiat., 144, 313.Google Scholar
Forstmeyer, W. M. (1938), Supp. Am. Journ. Psychiat., 94, 130.Google Scholar
Freudenberg, R. (1938), ibid., 94, 139.Google Scholar
Gagel, O. (1936), in Bumke, und Foerster, , Handb. Neur., 5, 482.Google Scholar
Gellhorn, E. (1938), Journ. Am. Med. Ass., 110, 1433.Google Scholar
Goldman, D. (1940) Endocrinology, 26, 612.Google Scholar
Grinker, R. R. (1939), Psychosomat. Med., 1, 19.Google Scholar
Heilbrunn, G. (1937), Wien. Min. Wochenschr. Google Scholar
Herbert, F. K., Bourne, M. C., and Groen, J. (1929), Biochem. J., 23, 339; (1930) ibid., 24, 291; (1931) Brit. Med. Journ., 1, 94.Google Scholar
Himsworth, H. P. (1935), Clin. Science, 2, 67.Google Scholar
Idem (1939), Lancet, ii, 1, 65, 118, 171.Google Scholar
Holmes, E. G. (1930), Biochem. J., 24, 914.Google Scholar
Jones, Maxwell (1940), Lancet, 2, 361.Google Scholar
Lawrence, R. D. (1940), Brit. Med. Journ., 2, 316.Google Scholar
Looney, J. M., and Cameron, D. E. (1937), Proc. Soc. Exp. Biol. and Med., 37, 253.Google Scholar
McGregor, J. S. (1941), M.D. Thesis (Glas.).Google Scholar
Idem and Sandison, R. A. (1940), Brit. Med. Journ., 2, 310.Google Scholar
Müller, M. (1937), Fortschr. d. Neurol. u. Psychiat., 9, 131.Google Scholar
Myers, G. B., and McKean, R. M. (1935), Am. Journ. Clin. Path., 5, 299.Google Scholar
Nicolajev, V. (1937), Ztschr. f. d. ges. Neurol. u. Psychiat., 157, 206.Google Scholar
Parker, C. S. (1940), Journ. Ment. Sci., 86, 645.Google Scholar
Pfister, H. O. (1938), Supp. Am. Journ. Psychiat., 94, 109.Google Scholar
Polatin, P., Spotnitz, H., and Wiesel, B. (1940), Arch. Neurol. and Psychiat., 43, 925.Google Scholar
Rabinowitch, I. M. (1928), Biochem. J., 22, 751.Google Scholar
Reese, H. H., and Van der Veer, A. (1938), Arch. Neurol. and Psychiat., 39, 232.Google Scholar
Sakel, M. (1935), Neue Behandlungmethode der Schizophrenie, Vienna.Google Scholar
Idem (1935). The Pharmacological Shock Treatment of Schizophrenia (Eng. trans.).Google Scholar
Stewart, D. (1928), Arch. Dis. Child., 3, 96.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.